EyeContactDX Appoints Dr. Carol Weitzman as Senior Strategic Advisor for AI Autism Screening
EyeContactDX has appointed Dr. Carol Weitzman, a leading developmental-behavioral pediatrician, as Senior Strategic Advisor to advance its AI-driven autism spectrum disorder (ASD) screening technology, announced in a press release.
Dr. Weitzman, known for her work in shaping ASD care guidelines, will guide EyeContactDX as it scales its eye-tracking screening solution for primary care use. The company’s platform applies AI and computer vision to detect visual biomarkers related to ASD using standard commercial tablets, eliminating the need for specialized hardware or trained operators.
EyeContactDX’s technology aims to provide pediatricians with an objective, accessible screening tool that integrates into existing clinical workflows. The company is preparing for deployments across key U.S. markets to support earlier detection and intervention for children at risk of ASD.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Sep 29 Truven launches MarketScan Snapshot for healthcare data checks Sep 29 Omega Healthcare Wins Gold in 2026 AI Breakthrough Awards Sep 29 Phylo Launches Target Atlas for Drug Target Prioritization Sep 29 ChromAgeNet Detects Aging Signs in Blood Stem Cell Images Sep 29 Axxess Partners With Eazewell for Hospice Family SupportLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Industry analysis
2025 Global Business Services Agenda: Gen AI Takes Center Stage
This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.
Read moreYou may also like
ARPA-H Awards UpDoc Up to $9.2 Million for Clinical AI
HealthIQ Solutions and Eirion.ai Partner on Predictive AI for Remote Care
Cellular Intelligence Adds Yann LeCun and Three Scientists to Advisory Board
Atman Health Wins ARPA-H Award to Build Heart Failure AI
QC Healthcare Partners With Sanguina for AI Blood Health Screening
Daily AI Brief: the AI news that matters, in your inbox.